SHERRIE EAVES: Open Payments
NPI 1518711951 · BUTTE, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$581 in 24 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $581
Food & beverage: $470Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 7 | $238 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $95 |
| Vanda Pharmaceuticals Inc. | 4 | $86 |
| Neurocrine BioSciences, Inc. | 3 | $72 |
| Janssen Pharmaceuticals, Inc | 3 | $53 |
| Lundbeck LLC | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: CAPLYTA, FANAPT, INGREZZA, UZEDY, AUSTEDO XR, INVEGA, REXULTI, INVEGA SUSTENNA.
Industry payments across MT — which companies pay providers there.
